1. Disc degeneration could be recovered after chemonucleolysis with condoliase.-1 year clinical outcome of condoliase therapy
- Author
-
Yuh Watanabe, Keiichi Nakai, Tomohiro Yamada, Yukihiro Matsuyama, Tomohiko Hasegawa, Tomohiro Banno, Koichiro Ide, Shin Oe, Go Yoshida, Kenta Kurosu, Yu Yamato, Hideyuki Arima, and Yuki Mihara
- Subjects
Adult ,Male ,medicine.medical_specialty ,Visual analogue scale ,Radiography ,Intervertebral Disc Degeneration ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Back pain ,Humans ,Orthopedics and Sports Medicine ,Adverse effect ,030222 orthopedics ,Lumbar Vertebrae ,medicine.diagnostic_test ,business.industry ,Intervertebral Disc Chemolysis ,Magnetic resonance imaging ,Middle Aged ,Oswestry Disability Index ,Surgery ,Treatment Outcome ,Back Pain ,Disc degeneration ,CONDOLIASE ,Female ,medicine.symptom ,business ,Intervertebral Disc Displacement ,030217 neurology & neurosurgery - Abstract
Background Condoliase-induced chemonucleolysis is a less-invasive alternative treatment for lumbar disc herniation (LDH); however, its long-term clinical outcome is still unclear. This study aimed to investigate 1-year clinical outcomes and assess radiographs after chemonucleolysis with condoliase. Methods We enrolled patients with LDH who received condoliase injection with a follow-up period of >1 year. Sixty patients (37 men, 23 women; mean age, 44.5 ± 18.9 years; mean follow-up period, 22.0 ± 6.0 months) were analyzed. Changes in disc height and degeneration were evaluated using magnetic resonance imaging. Visual analog scale (VAS) scores for leg and back pain and the Oswestry disability index (ODI) were obtained. All data were assessed at baseline, 1-month, 3-month, and 1-year follow-up. Results Surgical treatment was subsequently required in 8 patients (12.5%) after condoliase therapy. Their ODI and VAS scores for leg pain and back pain significantly improved at 1 year, as in those who received condoliase therapy only. On MRI, progression of Pfirrmann grade was observed in 23 patients (44.2%) at 3 months; however, 8 patients recovered to baseline at 1 year. The mean disc height decreased at 3 months; however, it recovered at 1 year. Disc height recovery (disc recovery rate >50%) was observed in 30.8% of the patients. Patients with disc height recovery were significantly younger than those without. Patients with longer symptom duration (≥1 year) showed significantly lower rates of effectiveness compared with those with shorter symptom durations ( Conclusions Chemonucleolysis with condoliase is a safe and minimally invasive treatment. Disc degeneration induced by chemonucleolysis could be recovered, particularly in younger patients. Prolonged symptom duration had adverse effects on outcome; thus, therapeutic intervention at the optimal time is needed.
- Published
- 2022
- Full Text
- View/download PDF